{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:06:31Z","timestamp":1784077591720,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH\/NIAID"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01472-2","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:07:27Z","timestamp":1778490447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A BcfA-containing intranasal vaccine generated TH17 immunity and reduced B. bronchiseptica colonization and disease in mice"],"prefix":"10.1038","volume":"11","author":[{"given":"Alexa R.","family":"Aubrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse M.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Shamseldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni B.","family":"DeLucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara N.","family":"Corps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendar","family":"Deora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purnima","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"1472_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cvsm.2019.10.009","volume":"50","author":"KL Reagan","year":"2020","unstructured":"Reagan, K. L. & Sykes, J. E. Canine infectious respiratory disease. Vet. Clin. North Am. Small Anim. Pr. 50, 405\u2013418 (2020).","journal-title":"Vet. Clin. North Am. Small Anim. Pr."},{"key":"1472_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","volume":"18","author":"S Mattoo","year":"2005","unstructured":"Mattoo, S. & Cherry, J. D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol Rev. 18, 326\u2013382 (2005).","journal-title":"Clin. Microbiol Rev."},{"key":"1472_CR3","doi-asserted-by":"publisher","first-page":"e2014031","DOI":"10.4084\/mjhid.2014.031","volume":"6","author":"AT Yacoub","year":"2014","unstructured":"Yacoub, A. T. et al. Bordetella bronchiseptica in the immunosuppressed population - a case series and review. Mediterr. J. Hematol. Infect. Dis. 6, e2014031 (2014).","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"1472_CR4","doi-asserted-by":"publisher","first-page":"e28244","DOI":"10.1097\/MD.0000000000028244","volume":"100","author":"VR Gujju","year":"2021","unstructured":"Gujju, V. R. et al. Bordetella bronchiseptica infections in patients with HIV\/AIDS: a case report and review of the literature. Med. (Baltim.) 100, e28244 (2021).","journal-title":"Med. (Baltim.)"},{"key":"1472_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jcf.2013.08.002","volume":"13","author":"C Brady","year":"2014","unstructured":"Brady, C. et al. Bordetella bronchiseptica in a pediatric Cystic Fibrosis center. J. Cyst. Fibros. 13, 43\u201348 (2014).","journal-title":"J. Cyst. Fibros."},{"key":"1472_CR6","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1128\/IAI.01453-13","volume":"82","author":"N Sukumar","year":"2014","unstructured":"Sukumar, N. et al. Comparative analyses of a cystic fibrosis isolate of Bordetella bronchiseptica reveal differences in important pathogenic phenotypes. Infect. Immun. 82, 1627\u20131637 (2014).","journal-title":"Infect. Immun."},{"key":"1472_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1863-2378.2011.01446.x","volume":"59","author":"KB Register","year":"2012","unstructured":"Register, K. B. et al. Bordetella bronchiseptica in a paediatric cystic fibrosis patient: possible transmission from a household cat. Zoonoses Public Health 59, 246\u2013250 (2012).","journal-title":"Zoonoses Public Health"},{"key":"1472_CR8","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1086\/514761","volume":"28","author":"MS Dworkin","year":"1999","unstructured":"Dworkin, M. S. et al. Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 28, 1095\u20131099 (1999).","journal-title":"Clin. Infect. Dis."},{"key":"1472_CR9","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3389\/fimmu.2019.01377","volume":"10","author":"A Muhammad","year":"2019","unstructured":"Muhammad, A. et al. Subcutaneous immunization of dogs with Bordetella bronchiseptica bacterial ghost vaccine. Front Immunol. 10, 1377 (2019).","journal-title":"Front Immunol."},{"key":"1472_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.tvjl.2015.02.006","volume":"204","author":"JA Ellis","year":"2015","unstructured":"Ellis, J. A. How well do vaccines for Bordetella bronchiseptica work in dogs? A critical review of the literature 1977-2014. Vet. J. 204, 5\u201316 (2015).","journal-title":"Vet. J."},{"key":"1472_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/vetreco-2018-000285","volume":"5","author":"MM Scott-Garrard","year":"2018","unstructured":"Scott-Garrard, M. M., Chiang, Y. W. & David, F. Comparative onset of immunity of oral and intranasal vaccines against challenge with Bordetella bronchiseptica. Vet. Rec. Open 5, e000285 (2018).","journal-title":"Vet. Rec. Open"},{"key":"1472_CR12","doi-asserted-by":"crossref","unstructured":"Hall J. M. et al. Opposing effects of acellular and whole cell pertussis vaccines on Bordetella pertussis biofilm formation, Siglec-F+ neutrophil recruitment and bacterial clearance in mouse nasal tissues. bioRxiv (2024).","DOI":"10.1101\/2024.01.23.576795"},{"key":"1472_CR13","doi-asserted-by":"crossref","unstructured":"Chasaide C. N. & Mills, K. H. G. Next-generation pertussis vaccines based on the induction of protective T cells in the respiratory tract. Vaccines 8, 621 (2020).","DOI":"10.3390\/vaccines8040621"},{"key":"1472_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1128\/iai.61.2.399-410.1993","volume":"61","author":"KH Mills","year":"1993","unstructured":"Mills, K. H. et al. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61, 399\u2013410 (1993).","journal-title":"Infect. Immun."},{"key":"1472_CR15","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.4049\/jimmunol.1000105","volume":"185","author":"A Dunne","year":"2010","unstructured":"Dunne, A. et al. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J. Immunol. 185, 1711\u20131719 (2010).","journal-title":"J. Immunol."},{"key":"1472_CR16","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1128\/JB.00009-07","volume":"189","author":"N Sukumar","year":"2007","unstructured":"Sukumar, N. et al. Differential Bvg phase-dependent regulation and combinatorial role in pathogenesis of two Bordetella paralogs, BipA and BcfA. J. Bacteriol. 189, 3695\u20133704 (2007).","journal-title":"J. Bacteriol."},{"key":"1472_CR17","doi-asserted-by":"crossref","unstructured":"Yount K. S. et al. Bordetella colonization factor A (BcfA) elicits protective immunity against bordetella bronchiseptica in the absence of an additional adjuvant. Infect Immun. 87, 10\u20131128 (2019).","DOI":"10.1128\/IAI.00506-19"},{"key":"1472_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.4049\/jimmunol.2200297","volume":"210","author":"MM Shamseldin","year":"2023","unstructured":"Shamseldin, M. M. et al. Prime-pull immunization of mice with a BcfA-adjuvanted vaccine elicits sustained mucosal immunity that prevents SARS-CoV-2 infection and pathology. J. Immunol. 210, 1257\u20131271 (2023).","journal-title":"J. Immunol."},{"key":"1472_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1181876","volume":"14","author":"KS Yount","year":"2023","unstructured":"Yount, K. S. et al. Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization. Front Immunol. 14, 1181876 (2023).","journal-title":"Front Immunol."},{"key":"1472_CR20","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1128\/iai.62.8.3381-3390.1994","volume":"62","author":"PA Cotter","year":"1994","unstructured":"Cotter, P. A. & Miller, J. F. BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect. Immun. 62, 3381\u20133390 (1994).","journal-title":"Infect. Immun."},{"key":"1472_CR21","doi-asserted-by":"crossref","unstructured":"Caution K. et al. Evaluation of host-pathogen responses and vaccine efficacy in mice. J. Vis. Exp. 144, 10\u20133791 (2019).","DOI":"10.3791\/58930-v"},{"key":"1472_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nprot.2014.005","volume":"9","author":"KG Anderson","year":"2014","unstructured":"Anderson, K. G. et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9, 209\u2013222 (2014).","journal-title":"Nat. Protoc."},{"key":"1472_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4049\/jimmunol.1602051","volume":"199","author":"MM Wilk","year":"2017","unstructured":"Wilk, M. M. et al. Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice with Bordetella pertussis. J. Immunol. 199, 233\u2013243 (2017).","journal-title":"J. Immunol."},{"key":"1472_CR24","doi-asserted-by":"publisher","first-page":"e1003264","DOI":"10.1371\/journal.ppat.1003264","volume":"9","author":"PJ Ross","year":"2013","unstructured":"Ross, P. J. et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog. 9, e1003264 (2013).","journal-title":"PLoS Pathog."},{"key":"1472_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1365-3083.2010.02410.x","volume":"72","author":"C Quinello","year":"2010","unstructured":"Quinello, C. et al. Passive acquisition of protective antibodies reactive with Bordetella pertussis in newborns via placental transfer and breast-feeding. Scand. J. Immunol. 72, 66\u201373 (2010).","journal-title":"Scand. J. Immunol."},{"key":"1472_CR26","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1128\/IAI.69.8.4846-4850.2001","volume":"69","author":"SM Hellwig","year":"2001","unstructured":"Hellwig, S. M. et al. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect. Immun. 69, 4846\u20134850 (2001).","journal-title":"Infect. Immun."},{"key":"1472_CR27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1292\/jvms.21-0494","volume":"84","author":"H Kameyama","year":"2022","unstructured":"Kameyama, H. et al. Pathogenicity of Bordetella bronchiseptica isolated from apparently healthy rabbits in guinea pig, rat, and mouse. J. Vet. Med Sci. 84, 574\u2013581 (2022).","journal-title":"J. Vet. Med Sci."},{"key":"1472_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00304-21","volume":"89","author":"JM Hall","year":"2021","unstructured":"Hall, J. M. et al. Reinvestigating the coughing rat model of pertussis to understand Bordetella pertussis pathogenesis. Infect. Immun. 89, e0030421 (2021).","journal-title":"Infect. Immun."},{"key":"1472_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00346-21","volume":"89","author":"JM Hall","year":"2021","unstructured":"Hall, J. M. et al. Mucosal immunization with DTaP confers protection against Bordetella pertussis infection and cough in Sprague-Dawley rats. Infect. Immun. 89, e0034621 (2021).","journal-title":"Infect. Immun."},{"key":"1472_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00520-23","volume":"92","author":"GJ Bitzer","year":"2024","unstructured":"Bitzer, G. J. et al. Immunization with an mRNA DTP vaccine protects against pertussis in rats. Infect. Immun. 92, e0052023 (2024).","journal-title":"Infect. Immun."},{"key":"1472_CR31","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1128\/IAI.01076-08","volume":"77","author":"N Sukumar","year":"2009","unstructured":"Sukumar, N. et al. Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica. Infect. Immun. 77, 885\u2013895 (2009).","journal-title":"Infect. Immun."},{"key":"1472_CR32","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41385-021-00407-5","volume":"14","author":"L Borkner","year":"2021","unstructured":"Borkner, L. et al. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F(+) neutrophils. Mucosal Immunol. 14, 1183\u20131202 (2021).","journal-title":"Mucosal Immunol."},{"key":"1472_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/mi.2012.54","volume":"5","author":"R Higgs","year":"2012","unstructured":"Higgs, R. et al. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol. 5, 485\u2013500 (2012).","journal-title":"Mucosal Immunol."},{"key":"1472_CR34","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1086\/593682","volume":"175","author":"M Ryan","year":"1997","unstructured":"Ryan, M. et al. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175, 1246\u20131250 (1997).","journal-title":"J. Infect. Dis."},{"key":"1472_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103037","volume":"24","author":"X An","year":"2021","unstructured":"An, X. et al. Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2. iScience 24, 103037 (2021).","journal-title":"iScience"},{"key":"1472_CR36","doi-asserted-by":"crossref","unstructured":"King R. G. et al. Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 and fully protects mice from lethal challenge. Vaccines 9, 881 (2021).","DOI":"10.3390\/vaccines9080881"},{"key":"1472_CR37","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3389\/fimmu.2020.02171","volume":"11","author":"E Sasaki","year":"2020","unstructured":"Sasaki, E. et al. Immunogenicity and toxicity of different adjuvants can be characterized by profiling lung biomarker genes after nasal immunization. Front Immunol. 11, 2171 (2020).","journal-title":"Front Immunol."},{"key":"1472_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/imm.13526","volume":"167","author":"VA Correa","year":"2022","unstructured":"Correa, V. A., Portilho, A. I. & De Gaspari, E. Vaccines, adjuvants and key factors for mucosal immune response. Immunology 167, 124\u2013138 (2022).","journal-title":"Immunology"},{"key":"1472_CR39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrmicro3235","volume":"12","author":"JA Melvin","year":"2014","unstructured":"Melvin, J. A. et al. Bordetella pertussis pathogenesis: current and future challenges. Nat. Rev. Microbiol 12, 274\u2013288 (2014).","journal-title":"Nat. Rev. Microbiol"},{"key":"1472_CR40","doi-asserted-by":"crossref","unstructured":"Dewan K. K. et al. Acellular Pertussis vaccine components: today and tomorrow. Vaccines 8, 217 (2020).","DOI":"10.3390\/vaccines8020217"},{"key":"1472_CR41","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/s41385-018-0080-x","volume":"11","author":"AC Allen","year":"2018","unstructured":"Allen, A. C. et al. Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T(RM) cells. Mucosal Immunol. 11, 1763\u20131776 (2018).","journal-title":"Mucosal Immunol."},{"key":"1472_CR42","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/mi.2016.28","volume":"10","author":"D Christensen","year":"2017","unstructured":"Christensen, D. et al. Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses. Mucosal Immunol. 10, 260\u2013270 (2017).","journal-title":"Mucosal Immunol."},{"key":"1472_CR43","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez, E. V. et al. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942\u2013949 (2007).","journal-title":"Nat. Immunol."},{"key":"1472_CR44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/imcb.12306","volume":"98","author":"SK Davis","year":"2020","unstructured":"Davis, S. K. et al. Serum IgA Fc effector functions in infectious disease and cancer. Immunol. Cell Biol. 98, 276\u2013286 (2020).","journal-title":"Immunol. Cell Biol."},{"key":"1472_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1051\/vetres:2006010","volume":"37","author":"V Snoeck","year":"2006","unstructured":"Snoeck, V., Peters, I. R. & Cox, E. The IgA system: a comparison of structure and function in different species. Vet. Res 37, 455\u2013467 (2006).","journal-title":"Vet. Res"},{"key":"1472_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127339","volume":"14","author":"F Bohlander","year":"2023","unstructured":"Bohlander, F. A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases. Front Immunol. 14, 1127339 (2023).","journal-title":"Front Immunol."},{"key":"1472_CR47","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4161\/mabs.3.4.16092","volume":"3","author":"JE Bakema","year":"2011","unstructured":"Bakema, J. E. & van Egmond, M. Immunoglobulin A: a next generation of therapeutic antibodies? MAbs 3, 352\u2013361 (2011).","journal-title":"MAbs"},{"key":"1472_CR48","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.chembiol.2014.10.017","volume":"21","author":"W Kelton","year":"2014","unstructured":"Kelton, W. et al. IgGA: a \u201ccross-isotype\u201d engineered human Fc antibody domain that displays both IgG-like and IgA-like effector functions. Chem. Biol. 21, 1603\u20131609 (2014).","journal-title":"Chem. Biol."},{"key":"1472_CR49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1073\/pnas.1314688110","volume":"111","author":"JM Warfel","year":"2014","unstructured":"Warfel, J. M., Zimmerman, L. I. & Merkel, T. J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc. Natl. Acad. Sci. USA 111, 787\u2013792 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1472_CR50","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1128\/IAI.06310-11","volume":"80","author":"JM Warfel","year":"2012","unstructured":"Warfel, J. M. et al. Nonhuman primate model of pertussis. Infect. Immun. 80, 1530\u20131536 (2012).","journal-title":"Infect. Immun."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01472-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01472-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01472-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:01:22Z","timestamp":1784077282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01472-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1472"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01472-2","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"147"}}